Propanc Biopharma
PPCB
#11204
Rank
A$2.81 M
Marketcap
A$2.69
Share price
3.19%
Change (1 day)
101.68%
Change (1 year)

Earnings for Propanc Biopharma (PPCB)

Earnings in 2026 (TTM): -A$27.74 Million

According to Propanc Biopharma's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$2.53 Million, an increase over its 2023 earnings that were of -A$3.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Propanc Biopharma from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$27.74 Million
2024 -A$2.53 Million-36.3%
2023 -A$3.97 Million0.89%
2022 -A$3.93 Million-2.16%
2021 -A$4.02 Million18.75%
2020 -A$3.38 Million-60.41%
2019 -A$8.54 Million-14.46%
2018 -A$9.98 Million-13.29%
2017 -A$11.51 Million-22.86%
2016 -A$14.92 Million46.22%
2015 -A$10.21 Million351.36%
2014 -A$2.27 Million29.49%
2013 -A$1.75 Million-82.48%
2012 -A$9.97 Million-7.39%
2011 -A$10.76 Million